🔎 Trials Near Me

Akèy › Obèsite › Alabama › Huntsville

Etid klinik pou Obèsite nan Huntsville, AL

7 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Huntsville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Heart Center Research LLC, Huntsville
Laj 45 a 99 · Tout sèks · Mizajou Oct 5, 2026 · NCT07037433

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2
  • Heart Center Research, LLC, Huntsville
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Huntsville
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Huntsville
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Heart Center Research LLC, Huntsville
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3
  • AURORA-1 Clinical Site, Huntsville
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Huntsville
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725

Etid Obèsite nan lòt vil

Lòt etid nan Huntsville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.